Albendazole
Treatment for Cystic Echinococcosis
Typical Dosage: 10-15 mg/kg/day in two divided doses (max 800 mg/day)
Effectiveness
70%
Safety Score
65%
Clinical Trials
60
Participants
8K
Comparative Safety Scale(Higher is safer)
Cyanideâ ī¸
Methđ
CigarettesđŦ
Chemoâĸī¸
Alcoholđē
Morphineđ
Antibioticsđ
Tylenolđ
Exerciseđ
Waterđ§
65
DangerousModerateSafe
Treatment Details
Dosage Range
10-15 mg/kg/day in two divided doses (max 800 mg/day)
Time to Effect
3-6 months for initial response
Treatment Duration
3-6 months, often in cycles (e.g., 28 days on, 14 days off), up to 2 years for complex cases
Evidence Quality
HIGHConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$3,600
Monitoring:$1,500
Side Effect Mgmt:$500
Total Annual:$5,600
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATEOutcome-Based Costs
Cost per Responder
$8,000
Cost per Remission
$16,000
Comparison vs Surgical Excision
Cost Difference
$-27,650/year
Less expensive
QALY Difference
0.00 QALYs
Same outcomes
Dominance
No dominance
Prescription Access Economics
Risk Assessment
Requires Monitoring
YesNeeds lab work/checkups
Albendazole Outcomes
for Cystic Echinococcosis
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+70%
Remission Rate
+35%
Common Side Effects
Elevated liver enzymes (transient)
+15%
Gastrointestinal upset (nausea, pain)
+15%
Leukopenia/Neutropenia
+8%
Alopecia (reversible)
+5%
Headache
+8%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov